MeSH tree: D02.455.849.291.850.777
Currently incurable, peripheral neuropathies are common neurological complications of chemotherapy, causing persistent pain, tingling and burning sensations in the feet and hands, sometimes even after treatment has ended. ...
Oct 30, 2025
0
6
Scientists at Wake Forest University School of Medicine, in collaboration with researchers at Weill Cornell Medicine, have made a breakthrough in understanding why many cancer patients develop nerve damage after chemotherapy. ...
Oct 29, 2025
0
30
During and after chemotherapy, nearly half of cancer patients endure circadian rhythm disruptions, which worsens treatment side effects. Because the body's primary rhythm pacemaker is in the brain, this suggests that perhaps ...
Sep 8, 2025
1
13
Drug-coated stents and balloons were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in two trials in peripheral artery disease (PAD), according to late-breaking research ...
Sep 1, 2025
0
10
University of Arizona researchers devised a new method to deliver cancer chemotherapy drugs to pancreatic and breast cancer tumors more effectively and with less damage to healthy tissues than standard forms of chemotherapy. ...
Aug 21, 2025
0
27
The official results of the BRACELET-01 (PrECOG 0113) trial have been published in Clinical Cancer Research, detailing the safety and efficacy of pelareorep, an investigational oncolytic virus immunotherapy, when added to ...
Jun 24, 2025
0
27
Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United States annually. CD8+ T cells that normally kill cancer cells often become exhausted and stop.
Mar 28, 2025
0
31
A new study led by a George Washington University Cancer Center researcher found that cold therapy protects breast cancer patients from nerve pain caused by chemotherapy.
Feb 20, 2025
0
21
Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer Research Center (DKFZ) and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine ...
Feb 17, 2025
0
63
A joint research team from the LKS Faculty of Medicine (HKUMed) and the Faculty of Science at the University of Hong Kong has uncovered an unexpected interaction between chemotherapeutic agents and a crucial efficacy marker.
Feb 11, 2025
0
29
